首页> 外文期刊>International Journal of Pharmaceutics >Controlled poly(l-lactide-co-trimethylene carbonate) delivery system of cyclosporine A and rapamycine--the effect of copolymer chain microstructure on drug release rate.
【24h】

Controlled poly(l-lactide-co-trimethylene carbonate) delivery system of cyclosporine A and rapamycine--the effect of copolymer chain microstructure on drug release rate.

机译:环孢菌素A和雷帕霉素的受控聚(l-丙交酯-碳酸三亚甲基酯)递送系统-共聚物链微结构对药物释放速率的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The effect of poly(L-lactide-co-TMC) chain microstructure (and its changes during degradation) on immunosuppressive drugs' release process was analyzed. Three kinds of poly(L-lactide-co-TMC) (PLATMC)--two semiblock and one random were used to prepare matrices containing cyclosporine A or rapamycine and drug free matrices. All of them degraded slowly enough to provide long term delivery of immunosuppressive agents. Moreover, copolymer chain microstructure determined the effect of drug loading on the degradation process. It was observed that matrices without drug obtained from semiblock copolymer degraded differently than matrices containing cyclosporine A or rapamycine, whereas all kinds of matrices obtained from random PLATMC degraded in similar way. This is the evidence that the only in case of semiblock copolymer factors concerning the presence of drug and the kind of drug influenced degradation process. Based on the obtained results, correlations between copolymer degradation and drug release process are proposed. According to our outcomes, regular drug release process may be obtained from highly randomized copolymers (R approximately 1) that remain amorphous during degradation process. Determination of this factor may help in development of biodegradable systems, in which drug release rate and profile can be tailored by synthesis of polymer with appropriate chain microstructure.
机译:分析了聚(L-丙交酯-co-TMC)链微结构(及其降解过程中的变化)对免疫抑制药物释放过程的影响。三种聚(L-丙交酯-共-TMC)(PLATMC)-两个半嵌段和一个随机用于制备包含环孢霉素A或雷帕霉素的基质和不含药物的基质。它们全部降解得足够缓慢以提供免疫抑制剂的长期递送。此外,共聚物链的微观结构决定了药物负载量对降解过程的影响。观察到,从半嵌段共聚物获得的不含药物的基质的降解与含有环孢菌素A或雷帕霉素的基质的降解不同,而从无规PLATMC获得的所有基质的降解均相似。这是仅在半嵌段共聚物情况下有关药物的存在和药物种类的因素影响降解过程的证据。基于获得的结果,提出了共聚物降解与药物释放过程之间的相关性。根据我们的结果,可以从降解过程中保持无定形的高度无规共聚物(R约1)获得常规的药物释放过程。确定该因素可能有助于开发可生物降解的系统,在该系统中,可以通过合成具有适当链微结构的聚合物来调整药物的释放速率和分布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号